Abstract
To develop a methodology for bone-specific delivery of drugs, a bone-targeting gem-bisphosphonate was used as a carrier of drugs. We had synthesized five compounds, which were a new class of potential bone-targeting reagents for bone tumors consisting of melphalan linked to a gem-bisphosphonate moiety through an amide linkage. The conjugates showed a high affinity to hydroxyapatite in vitro.
Keywords: Bone-targeting, gem-bisphosphonates, melphalan, bone tumors
Letters in Organic Chemistry
Title: Synthesis of Melphalan-Gem-Bisphosphonate Conjugation to Bone Tumors and Study of Affinity to Hydroxyapatite In Vitro
Volume: 5 Issue: 3
Author(s): Qinglin Jiang, Li Yang, Li Hai and Yong Wu
Affiliation:
Keywords: Bone-targeting, gem-bisphosphonates, melphalan, bone tumors
Abstract: To develop a methodology for bone-specific delivery of drugs, a bone-targeting gem-bisphosphonate was used as a carrier of drugs. We had synthesized five compounds, which were a new class of potential bone-targeting reagents for bone tumors consisting of melphalan linked to a gem-bisphosphonate moiety through an amide linkage. The conjugates showed a high affinity to hydroxyapatite in vitro.
Export Options
About this article
Cite this article as:
Jiang Qinglin, Yang Li, Hai Li and Wu Yong, Synthesis of Melphalan-Gem-Bisphosphonate Conjugation to Bone Tumors and Study of Affinity to Hydroxyapatite In Vitro, Letters in Organic Chemistry 2008; 5 (3) . https://dx.doi.org/10.2174/157017808783955862
DOI https://dx.doi.org/10.2174/157017808783955862 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers